-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $70

Benzinga·09/28/2026 12:25:21
Listen to the news
Guggenheim analyst Yatin Suneja initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Buy rating and announces Price Target of $70.